| Old Articles: <Older 6391-6400 Newer> |
|---|
 |
The Motley Fool
June 15, 2010
Luke Timmerman |
Pfizer Dumps Trubion's Lead Rheumatoid Arthritis Drug, Keeps Next-Gen Product Alive Pfizer tells Trubion: "It's not you. It's me. Well, actually it is you -- I've met someone new."   |
InternetNews
June 14, 2010 |
Lax Data Security Results in Heavy Fines Five California hospitals got an expensive reminder of just how serious the state is about protecting patients' sensitive data. Expect more of the same in the near future. |
The Motley Fool
June 14, 2010
Rich Smith |
This Just In: Upgrades and Downgrades All-Star analyst Brean Murray comes out with a downgrade on Intuitive Surgical, saying hard times may be ahead for the company. |
The Motley Fool
June 14, 2010
Brian Orelli |
No Approval? No Problem! Investors shrug off Human Genome's news about its hepatitis C drug Zalbin. |
The Motley Fool
June 14, 2010
Bruce Bigelow |
Genetic Testing Companies in San Diego, Boston, and San Francisco Studying FDA Letters The letters notify the companies that genome-sequencing tests they offer to consumers are medical devices that require the agency's approval. |
The Motley Fool
June 11, 2010
Brian Orelli |
Pfizer and Bristol Coagulate Against Clots Let's see how apixaban does against warfarin before we break out the "blockbuster" stamp. |
The Motley Fool
June 11, 2010
Brian Orelli |
Double-Digit Pop Because the Drug Still Works? Developments at Mannkind's shareholder meeting send stock soaring. |
The Motley Fool
June 11, 2010
Brian Orelli |
25 to 0! Now That's a Ringing Endorsement Novartis flies through its advisory panel meeting nearly unscathed. |
BusinessWeek
June 10, 2010
Dune Lawrence |
Nurses: Fed Up and Not Taking It Anymore Hospitals and a new nurses' union are taking a tough line on salaries and benefits now, in advance of the cost pressures from Obamacare. |
The Motley Fool
June 10, 2010
Brian Orelli |
Cancel the Clowns: Icahn Avoids a Circus The billionaire investor backs down from a fight. He withdrew his slate of candidates to join Genzyme's board yesterday. |
| <Older 6391-6400 Newer> Return to current articles. |
